Geneseeq Technology (also known as 世和基因, Geneseeq Tech) is a biotech company that is focused on the research and clinical translation of next-generation sequencing (NGS) in the field of personalized medicine. It provides users with ctDNA testing services based on its independently developed system, which involves the fields of early and mid-stage cancer patients' auxiliary diagnosis, postoperative residue, and recurrence detection.
|Employees (est.) (May 2020)||18||(+13%)|
Geneseeq total Funding
Geneseeq latest funding size
Time since last funding
|5 months ago|
|SBCVC, Lilly Asia Ventures, Cowin Capital, Huatai Securities Co., D.Z. Capital, Beijing Beilu Pharmaceutical, Eastern Investment, Industrial Securities Capital, Huatai Health Fund, Boyuanhongsheng, Sealand Innovation, Huatai Healthcare Investment Fund, China Reform Holdings Corporation, DNV Capital|
Geneseeq has 21 Twitter Followers. The number of followers has increased 15.1% month over month and increased 40% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Geneseeq founded?
Geneseeq was founded in 2008.
How many employees does Geneseeq have?
Geneseeq has 18 employees.
Who are Geneseeq competitors?
Competitors of Geneseeq include Full Genomes, OncoCell MDx and SageMedic.
Where is Geneseeq headquarters?
Geneseeq headquarters is located at 101 College St, Toronto.
Where are Geneseeq offices?
Geneseeq has an office in Toronto.
How many offices does Geneseeq have?
Geneseeq has 1 office.
Receive alerts for 300+ data fields across thousands of companies